Copyright © 2012 Qianming Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. J. Galli and M. Tsai, “Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity,” European Journal of Immunology, vol. 40, no. 7, pp. 1843–1851, 2010. View at Publisher · View at Google Scholar · View at Scopus
2. E. Garbuzenko, A. Nagler, D. Pickholtz et al., “Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis,” Clinical and Experimental Allergy, vol. 32, no. 2, pp. 237–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
3. D. A. Groneberg, F. Serowka, N. Peckenschneider et al., “Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1,” Journal of Neuroimmunology, vol. 161, no. 1-2, pp. 87–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
4. T. C. Theoharides and D. E. Cochrane, “Critical role of mast cells in inflammatory diseases and the effect of acute stress,” Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
5. J. Kalesnikoff and S. J. Galli, “New developments in mast cell biology,” Nature Immunology, vol. 9, no. 11, pp. 1215–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
6. M. Metz, M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli, “Mast cells in the promotion and limitation of chronic inflammation,” Immunological Reviews, vol. 217, no. 1, pp. 304–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
7. K. Norrby, “Mast cells and angiogenesis: review article,” APMIS, vol. 110, no. 5, pp. 355–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
8. L. B. Schwartz, K. Sakai, T. R. Bradford et al., “The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis,” Journal of Clinical Investigation, vol. 96, no. 6, pp. 2702–2710, 1995. View at Scopus
9. S. Jogie-Brahim, H. K. Min, Y. Fukuoka, H. Z. Xia, and L. B. Schwartz, “Expression of alpha-tryptase and beta-tryptase by human basophils,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1086–1092, 2004.
10. Y. Fukuoka and L. B. Schwartz, “Human β-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors,” Biochemistry, vol. 43, no. 33, pp. 10757–10764, 2004. View at Publisher · View at Google Scholar · View at Scopus
11. Y. Fukuoka and L. B. Schwartz, “The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized β-tryptase to form monomers that are inactive at neutral pH and active at acidic pH,” Journal of Immunology, vol. 176, no. 5, pp. 3165–3172, 2006. View at Scopus
12. G. Bazzoni and E. Dejana, “Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis,” Physiological Reviews, vol. 84, no. 3, pp. 869–901, 2004. View at Publisher · View at Google Scholar · View at Scopus
13. O. E. Kolokitha and E. Chatzistavrou, “Allergic reactions to nickel-containing orthodontic appliances: clinical signs and treatment alternatives,” World Journal of Orthodontics, vol. 9, no. 4, pp. 399–406, 2008. View at Scopus
14. T. Imamura, A. Dubin, W. Moore, R. Tanaka, and J. Travis, “Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens,” Laboratory Investigation, vol. 74, no. 5, pp. 861–870, 1996. View at Scopus
15. C. Jacob, P. C. Yang, D. Darmoul et al., “Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and β-arrestins,” Journal of Biological Chemistry, vol. 280, no. 36, pp. 31936–31948, 2005. View at Publisher · View at Google Scholar · View at Scopus
16. M. Lytinas, D. Kempuraj, M. Huang et al., “Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine,” Allergy and Asthma Proceedings, vol. 23, no. 1, pp. 45–51, 2002. View at Scopus
17. Y. Itoh, T. Sendo, and R. Oishi, “Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function,” Journal of Pharmacological Sciences, vol. 97, no. 1, pp. 14–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
18. T. Murohara, J. R. Horowitz, M. Silver et al., “Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin,” Circulation, vol. 97, no. 1, pp. 99–107, 1998. View at Scopus
19. D. O. Bates and S. J. Harper, “Regulation of vascular permeability by vascular endothelial growth factors,” Vascular Pharmacology, vol. 39, no. 4-5, pp. 225–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
20. D. Feng, J. A. Nagy, R. A. Brekken et al., “Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF- expressing tumors and adenoviral vectors,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 4, pp. 545–556, 2000. View at Scopus
21. L. F. Brown, S. M. Olbricht, B. Berse et al., “Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions,” Journal of Immunology, vol. 154, no. 6, pp. 2801–2807, 1995. View at Scopus
22. Y. Zhang, H. Matsuo, and E. Morita, “Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis,” Archives of Dermatological Research, vol. 297, no. 9, pp. 425–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
23. P. M. Davison, K. Bensch, and M. A. Karasek, “Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture,” Journal of Investigative Dermatology, vol. 75, no. 4, pp. 316–321, 1980. View at Scopus
24. P. M. Davison and M. A. Karasek, “Human dermal microvascular endothelial cells in vitro: effect of cyclic AMP on cellular morphology and proliferation rate,” Journal of Cellular Physiology, vol. 106, no. 2, pp. 253–258, 1981. View at Scopus
25. R. M. Marks, M. Czerniecki, and R. Penny, “Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture,” In Vitro Cellular & Developmental Biology, vol. 21, no. 11, pp. 627–635, 1985. View at Scopus
26. K. Gupta, S. Ramakrishnan, P. V. Browne, A. Solovey, and R. P. Hebbel, “A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor,” Experimental Cell Research, vol. 230, no. 2, pp. 244–251, 1997. View at Publisher · View at Google Scholar · View at Scopus
27. V. V. Orlova, M. Economopoulou, F. Lupu, S. Santoso, and T. Chavakis, “Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2703–2714, 2006. View at Publisher · View at Google Scholar · View at Scopus
28. Q. Bai, L. Xu, G. Kakiyama et al., “Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells,” Atherosclerosis, vol. 214, no. 2, pp. 350–356, 2011. View at Publisher · View at Google Scholar · View at Scopus
29. X. P. Yang, Y. Li, Y. Wang, Y. Wang, and P. Wang, “β-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia,” Leukemia & Lymphoma, vol. 51, no. 8, pp. 1550–1558, 2010. View at Publisher · View at Google Scholar · View at Scopus
30. C. P. Sommerhoff, W. Bode, G. Matschiner, A. Bergner, and H. Fritz, “The human mast cell tryptase tetramer: a fascinating riddle solved by structure,” Biochimica et Biophysica Acta, vol. 1477, no. 1-2, pp. 75–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
31. S. Ren, A. E. Lawson, M. Carr, C. M. Baumgarten, and L. B. Schwartz, “Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12,” Journal of Immunology, vol. 159, no. 7, pp. 3540–3548, 1997. View at Scopus
32. L. B. Schwartz, “Tryptase: a mast cell serine protease,” Methods in Enzymology, vol. 244, pp. 88–100, 1994. View at Publisher · View at Google Scholar · View at Scopus
33. R. J. Blair, H. Meng, M. J. Marchese et al., “Human mast cells stimulate vascular tube formation. tryptase is a novel, potent angiogenic factor,” Journal of Clinical Investigation, vol. 99, no. 11, pp. 2691–2700, 1997. View at Scopus
34. D. D. Metcalfe, D. Baram, and Y. A. Mekori, “Mast cells,” Physiological Reviews, vol. 77, no. 4, pp. 1033–1079, 1997. View at Scopus
35. H. F. Dvorak, L. F. Brown, M. Detmar, and A. M. Dvorak, “Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis,” The American Journal of Pathology, vol. 146, no. 5, pp. 1029–1039, 1995. View at Scopus
36. Y. C. Lee, Y. G. Kwak, and C. H. Song, “Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma,” Journal of Immunology, vol. 168, no. 7, pp. 3595–3600, 2002. View at Scopus
37. C. G. Lee, H. Link, P. Baluk et al., “Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung,” Nature Medicine, vol. 10, no. 10, pp. 1095–1103, 2004. View at Publisher · View at Google Scholar · View at Scopus
38. K. S. Lee, S. R. Kim, H. S. Park, G. Y. Jin, and Y. C. Lee, “Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression,” Journal of Allergy and Clinical Immunology, vol. 114, no. 5, pp. 1093–1099, 2004. View at Publisher · View at Google Scholar · View at Scopus
39. H. F. Dvorak, “Discovery of vascular permeability factor (VPF),” Experimental Cell Research, vol. 312, no. 5, pp. 522–526, 2006. View at Publisher · View at Google Scholar · View at Scopus
40. D. Ribatti, “The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review,” British Journal of Haematology, vol. 128, no. 3, pp. 303–309, 2005. View at Publisher · View at Google Scholar · View at Scopus